Cargando…

Identification of potential natural inhibitors of the receptor-binding domain of the SARS-CoV-2 spike protein using a computational docking approach

Background: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the only zoonotic-origin CoV to reach the pandemic stage, to which neither an effective vaccine nor a specific therapy is available. The spike glycoprotein harbors the receptor-binding domain (RBD) that mediates th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathew, Shilu Mathew, Benslimane, Fatiha, Althani, Asmaa A., Yassine, Hadi M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	HBKU Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474837/ https://www.ncbi.nlm.nih.gov/pubmed/34604010 http://dx.doi.org/10.5339/qmj.2021.12

Ejemplares similares

Platforms Exploited for SARS-CoV-2 Vaccine Development
por: Mathew, Shilu, et al.
Publicado: (2020)

Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors
por: Mathew, Shilu, et al.
Publicado: (2018)

In silico virtual screening of lead compounds for major antigenic sites in respiratory syncytial virus fusion protein
por: Mathew, Shilu, et al.
Publicado: (2021)

Immunoinformatics prediction of potential immunodominant epitopes from human coronaviruses and association with autoimmunity
por: Mathew, Shilu, et al.
Publicado: (2022)

Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities
por: Al Khatib, Hebah A., et al.
Publicado: (2020)

Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding
por: Bozdaganyan, Marine E., et al.
Publicado: (2022)

Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds
por: Mathew, Shilu, et al.
Publicado: (2015)

Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2
por: Biswas, Suvro, et al.
Publicado: (2022)

Epidemiological, Molecular, and Clinical Features of Norovirus Infections among Pediatric Patients in Qatar
por: Mathew, Shilu, et al.
Publicado: (2019)

1833. Measuring Influenza HA Stem-Specific ADCC in Human Sera Using Novel Stabilized Stem Nanoparticle Probes
por: Smatti, Maria K, et al.
Publicado: (2019)

Screening of cryptogamic secondary metabolites as putative inhibitors of SARS-CoV-2 main protease and ribosomal binding domain of spike glycoprotein by molecular docking and molecular dynamics approaches
por: Prateeksha, G., et al.
Publicado: (2021)

Mixed Viral-Bacterial Infections and Their Effects on Gut Microbiota and Clinical Illnesses in Children
por: Mathew, Shilu, et al.
Publicado: (2019)

Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2
por: Sakib, Md Minhas Hossain, et al.
Publicado: (2021)

Homology Modeling and Molecular Dynamics-Driven Search for Natural Inhibitors That Universally Target Receptor-Binding Domain of Spike Glycoprotein in SARS-CoV-2 Variants
por: Ovchynnykova, Olha, et al.
Publicado: (2022)

Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach
por: Muhseen, Ziyad Tariq, et al.
Publicado: (2020)

Glycans on the SARS-CoV-2 Spike Control the Receptor Binding Domain Conformation
por: Henderson, Rory, et al.
Publicado: (2020)

The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein
por: Dokainish, Hisham M, et al.
Publicado: (2022)

Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein
por: Verma, Saroj, et al.
Publicado: (2022)

Conformational Dynamics of the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
por: Mamchur, Aleksandra A., et al.
Publicado: (2022)

An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor
por: Durojaye, Olanrewaju Ayodeji, et al.
Publicado: (2020)

Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach
por: Behera, Santosh Kumar, et al.
Publicado: (2021)

Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
por: Chi, Xiaojing, et al.
Publicado: (2020)

Identifying SARS-CoV-2 Drugs Binding to the Spike Fatty Acid Binding Pocket Using In Silico Docking and Molecular Dynamics
por: Piplani, Sakshi, et al.
Publicado: (2023)

Whole genome sequencing of marine organisms by Oxford Nanopore Technologies: Assessment and optimization of HMW‐DNA extraction protocols
por: Boughattas, Sonia, et al.
Publicado: (2021)

Silibinin as potential tool against SARS‐Cov‐2: In silico spike receptor‐binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects
por: Speciale, Antonio, et al.
Publicado: (2021)

Does the SARS-CoV-2 Spike Protein Receptor Binding Domain Interact Effectively with the DPP4 (CD26) Receptor? A Molecular Docking Study
por: Cameron, Kirsten, et al.
Publicado: (2021)

Repurposing the natural compounds as potential therapeutic agents for COVID-19 based on the molecular docking study of the main protease and the receptor-binding domain of spike protein
por: Eskandari, Vajiheh
Publicado: (2022)

Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
por: Hussain, Arif, et al.
Publicado: (2020)

Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain
por: Barh, Debmalya, et al.
Publicado: (2020)

Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain
por: Antonopoulos, Aristotelis, et al.
Publicado: (2020)

DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2
por: Cleri, Fabrizio, et al.
Publicado: (2021)

Insights into the conformation changes of SARS-CoV-2 spike receptor-binding domain on graphene
por: Du, Jianbin, et al.
Publicado: (2022)

The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression
por: Maffei, Mariano, et al.
Publicado: (2021)

A Fungal Defensin Targets the SARS−CoV−2 Spike Receptor−Binding Domain
por: Gao, Bin, et al.
Publicado: (2021)

Small Molecules Targeting SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain
por: Rodríguez, Yoel, et al.
Publicado: (2022)

Physicochemical Nature of SARS-CoV-2 Spike Protein Binding to Human Vimentin
por: Deptuła, Piotr, et al.
Publicado: (2023)

Computational insights into differential interaction of mammalian angiotensin-converting enzyme 2 with the SARS-CoV-2 spike receptor binding domain
por: Lupala, Cecylia Severin, et al.
Publicado: (2022)

Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity
por: Volpatti, Lisa R., et al.
Publicado: (2021)

Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity
por: Volpatti, Lisa R., et al.
Publicado: (2021)

Computational screening and biochemical analysis of Pistacia integerrima and Pandanus odorifer plants to find effective inhibitors against Receptor-Binding domain (RBD) of the spike protein of SARS-Cov-2
por: Kumar Paul, Gobindo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uduqvnks3oejeupna96b9j4urt